Go back to Resources
Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry
2001
Journal Article
Authors:
Location: Barcelona, Spain
Go back to Resources